JBIO (JBIO) reported AOCI of -$342K in Q1 2026.

How has JBIO's AOCI changed year-over-year?

JBIO's AOCI decreased by 784.0% year-over-year, from $50K to -$342K.

What is the long-term trend for JBIO's AOCI?

Over 4 years (2021 to 2025), JBIO's AOCI has grown at a 21.6% compound annual growth rate (CAGR), from -$59K to $129K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

JBIO JBIO AOCI

AOCI at other companies

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

Travere Therapeutics, Inc.TVTX

-$1.06M-26.0%

Vera TherapeuticsVERA

-$156K-124%

AnaptysBio, Inc.ANAB

-$146K-191%

Avalo TherapeuticsAVTX

-$6K—

Cullinan Therapeutics, Inc.CGEM

$127K-74.9%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's AOCI?: JBIO (JBIO) reported AOCI of -$342K in Q1 2026.
How has JBIO's AOCI changed year-over-year?: JBIO's AOCI decreased by 784.0% year-over-year, from $50K to -$342K.
What is the long-term trend for JBIO's AOCI?: Over 4 years (2021 to 2025), JBIO's AOCI has grown at a 21.6% compound annual growth rate (CAGR), from -$59K to $129K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.